CLINICAL_TRIALS
trial_result
· 2021-06-21
Clinical Trial Update: A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma [Phase 1, Phase 2]
Summary
A Phase I/II study evaluating [124I]mIBG PET/CT in metastatic neuroblastoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cancer Research UK | Conditions: Metastatic Neuroblastoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-06-21